Organigram (CVE OGI) opened at C$4.31 on Wednesday. Organigram has a 52 week low of C$1.95 and a 52 week high of C$5.68. The stock has a market capitalization of $526.95, a P/E ratio of -39.18 and a beta of 8.35.
Organigram (CVE:OGI) last announced its quarterly earnings data on Monday, January 29th. The company reported C($0.01) earnings per share (EPS) for the quarter, hitting the consensus estimate of C($0.01). The firm had revenue of C$2.69 million during the quarter, compared to the consensus estimate of C$2.86 million.
ILLEGAL ACTIVITY NOTICE: “Organigram (OGI) Given a C$5.50 Price Target by Canaccord Genuity Analysts” was first posted by Ticker Report and is the sole property of of Ticker Report. If you are reading this article on another publication, it was illegally copied and reposted in violation of US & international trademark and copyright legislation. The legal version of this article can be viewed at https://www.tickerreport.com/banking-finance/3254317/organigram-ogi-given-a-c5-50-price-target-by-canaccord-genuity-analysts.html.
OrganiGram Holdings Inc, through its subsidiary, Organigram Inc, produces and sells medical marijuana in Canada. The company was founded in 2013 and is based in Moncton, Canada.
Receive News & Ratings for Organigram Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Organigram and related companies with MarketBeat.com's FREE daily email newsletter.